Cancel

Advanced Ovarian Cancer and PARP Inhibitors: Clinical Insights and Impact on New Data

In this CME activity, Susana M. Campos, MD, MS, MPH, reviews some of the recent clinical developments in the treatment of patients with advanced ovarian cancer with PARP inhibitors. We welcome you to learn more about the updated data from key clinical studies of PARP inhibitor maintenance therapy in advanced ovarian cancer, and the implications of the results on the current and emerging concepts in ovarian cancer clinical practice. CONTENT AREAS • Platinum-sensitive recurrent ovarian cance...
Annenberg Center for Health Sciences at Eisenhower

Expert Perspectives on Practice-Changing Strategies for Improved Patient Outcomes in Multiple Myeloma - Part 1

STATEMENT OF NEED Multiple myeloma is a B-cell neoplasm that occurs primarily in older adults. The incidence is expected to rise in conjunction with the aging population. Because symptoms often do not appear until the malignancy is in advanced stages, early diagnosis is difficult, and the 5-year relative survival rate remains only 54% (ACS, 2021). Following diagnosis, management must be guided by cytogenic markers with prognostic significance and correct staging based upon these markers (NC...
i3 Health

Rising to the Challenge: The Evolving Landscape of Maintenance Therapy in Ovarian Cancer

Target Audience This activity is intended for medical oncologists and gynecologic oncologists, and other HCPs who provide care for patients with ovarian cancer. Program Overview The landscape of maintenance treatment options for ovarian cancer has been rapidly expanding and continues to evolve as new data emerge. Maintenance therapy with poly(ADP-ribose) polymerase (PARP) inhibitors and bevacizumab has demonstrated improvements in progression-free survival. A recent trial showed that main...
Postgraduate Institute for Medicine and Spire Learning

CIDP: Improving Timely Diagnosis, Assessment, and Treatment

TARGET AUDIENCE The educational design of this activity addresses the needs of neurologists, neuromuscular specialists, immunologists, primary care providers, hospitalists, emergency physicians, advanced practitioners, nurses, and pharmacists involved in the treatment of patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). STATEMENT OF NEED/PROGRAM OVERVIEW While CIDP is the most common of the acquired immune-mediated demyelinating neuropathies, it remains a c...
Global Education Group (Global) and PlatformQ Health Education, LLC.

Optimizing Treatment Sequencing for Patients With Relapsed/ Refractory Multiple Myeloma

Discover new developments in sequential treatment and clinical findings, evaluate strategies to manage and monitor adverse events, and initiating therapy for patients with relapsed/refractory Multiple Myeloma, and much more! Leading oncologist Shaji Kumar, Mayo Clinic Cancer Center, presents this in-depth discussion. Start the activity now! STATEMENT OF NEED Multiple myeloma (MM) is a B-cell neoplasm characterized by aberrant expansion of plasma cells within the bone marrow and extramed...
i3 Health

Current Issues Regarding Obesity Treatment and Chronic Weight Management

Target Audience This activity was developed for cardiologists, endocrinologists, primary care physicians, and other healthcare providers who treat patients’ obesity and other commonly associated diseases. Program Overview Obesity experts Drs. Apovian and Kushner delve into the complex and undertreated disease of obesity, addressing the importance of weight loss and chronic weight management. They discuss obesity as a chronic disease with its pathophysiologic basis, associated cardiometa...
Annenberg Center for Health Sciences at Eisenhower

Case Challenges in the Management of Bipolar Disorder: Patient-Centered Approaches

Target Audience The accredited activity is intended for psychiatrists, advanced practice psychiatry clinicians, and other health care providers involved in the care of patients with bipolar disorder. Program Overview Many patients with bipolar disorder do not receive a timely diagnosis. Once diagnosed, some patients linger on treatment plans that do not adequately control their symptoms, whereas others experience side effects that lead them to abandon their treatment plans. To ensure that...
Medical Education Resources and CMEology

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map